BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 733081)

  • 1. [The antisteatosic activity of 2-MPG (Thiola). Study with the (BSF) dynamic test and with liver biopsy before and after the treatment].
    Surrenti C; Arcangeli A; Casini A
    Minerva Med; 1978 Dec; 69(61):4251-6. PubMed ID: 733081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the liver cell clearance fraction before and after treatment with alpha-mercaptopropionylglycine in chronic hepatopathies].
    Cortinovis A; Paolini FA; Crippa A
    Arch Sci Med (Torino); 1979; 136(4):497-508. PubMed ID: 550750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of changes in certain immunoglobulin fractions in acute and chronic hepatopathies treated with alpha-mercaptopropionylglycine].
    Marinai E; Ulivieri P; Righi A
    Minerva Med; 1977 Dec; 68(62):4193-7. PubMed ID: 600464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cystine stone therapy with mercapto-propyonyl-glycine (MPG) (Thiola) (author's transl)].
    Terhorst B; Stuhlsatz HW
    Urologe A; 1975 Jul; 14(4):190-3. PubMed ID: 808002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of Thiola in post-hepatitis hepatic insufficiency].
    Precchia G; d'Amico A; Precchia E; Precchia A; Vela R
    Minerva Med; 1977 Jul; 68(36):2505-7. PubMed ID: 887229
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of acute and chronic liver disease as well as several malabsorption syndromes with 2 mercaptopropionylglycine MPG (thiola) (author's transl)].
    Markoff NG
    Schweiz Rundsch Med Prax; 1975 Jul; 64(30):958-61. PubMed ID: 1144310
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of the fraction of hepatocyte depuration before and after treatment with alpha-mercaptopropionylglycine in chronic hepatopathies].
    Cortinovis A; Paolini FA; Crippa A
    Minerva Med; 1979 Dec; 70(54):3709-13. PubMed ID: 523002
    [No Abstract]   [Full Text] [Related]  

  • 8. Alternative treatment of cystinuria with alpha-merkaptopropionylglycine, Thiola.
    Denneberg T; Jeppsson JO; Stenberg P
    Proc Eur Dial Transplant Assoc; 1983; 20():427-33. PubMed ID: 6657666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New therapeutic prospects in lead poisoning: alpha-mercaptopropionylglycine].
    Franco G; Malamani T; Scalisi L
    Minerva Med; 1979 Sep; 70(41):2811-9. PubMed ID: 492550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of 2 mercaptopropionylglycine on the cytotoxic activity of lymphocytes from patients with chronic active hepatitis against rabbit hepatocytes isolated and cultured in vitro].
    Mazzetti M; Guizzardi G; Meliconi R; Baraldini M; Stancari MV; Mazzoli M; Stefanini GF
    Boll Soc Ital Biol Sper; 1981 Jul; 57(14):1477-83. PubMed ID: 7295410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cystinuria with Thiola (alpha-mercaptopropionyl glycine).
    Remien A; Kallistratos G; Burchardt P
    Eur Urol; 1975; 1(5):227-8. PubMed ID: 1233187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and statistical study of the use of alpha-MPG in the treatment of viral hepatitis].
    Bosio G; Marietti G
    Minerva Med; 1978 May; 69(22):1495-501. PubMed ID: 683551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical aspects of cystinuria and its treatment by thiola (author's transl)].
    Zechner O; Latal D; Gründig E; Müller M
    Wien Klin Wochenschr; 1976 Feb; 88(3):101-5. PubMed ID: 960706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alpha-mercaptopropionylglycine (Thiola) in the treatment of chronic liver diseases with special reference to the effects of the drug on the index of prognosis in alcoholic cirrhosis].
    Mantero O; Conti F; Bertoli L
    Minerva Med; 1974 Feb; 65(9):460-7. PubMed ID: 4820725
    [No Abstract]   [Full Text] [Related]  

  • 15. [The action of thiopronine in the treatment of chronic recurrent pancreatitis. Double-blind study of 105 patients].
    Valente U; Campisi C; Barabino C; De Rosa E; Traverso C; Pozzati A; Fontana I
    Minerva Chir; 1983 Apr; 38(8):573-6. PubMed ID: 6346137
    [No Abstract]   [Full Text] [Related]  

  • 16. [Controlled clinical trial of 2-mercapto-propionyl-glycine in chronic hepatopathies].
    Dioguardi N; Ideo G; De Franchis R; Ronchi G
    Minerva Med; 1976 Mar; 67(11):676-81. PubMed ID: 1256687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tiopronine: new basic treatment for rheumatoid arthritis. Open study of 158 cases].
    Pasero G; Pellegrini P; Ciompi ML; Colamussi V; Barbieri P; Mazzoni MR
    Rev Rhum Mal Osteoartic; 1980 Mar; 47(3):163-8. PubMed ID: 7384725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic action of S-adenosylmethionine in some chronic hepatopathies].
    Labò G; Gasbarrini GB
    Minerva Med; 1975 May; 66(33):1563-70. PubMed ID: 1143692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term therapy of rheumatoid arthritis with alpha-mercaptopropionylglycine].
    Carrozzini B; Selvaggio G
    Minerva Med; 1982 May; 73(19):1301-4. PubMed ID: 6804890
    [No Abstract]   [Full Text] [Related]  

  • 20. [Basic therapy of rheumatoid arthritis with thiopronine. Preliminary results].
    Fossaluzza V; Di Benedetto P; Pinat F; Pasqualini M; Massarutto C; Pirrone S; Rossi P; Tosato F; Lucas C; Padovani R
    Minerva Med; 1983 Mar; 74(13):723-6. PubMed ID: 6339997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.